About Kayla Young
Form D filings for Phase Genomics in 2023 list Kayla Young as executive officer.
Kayla Young first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Kayla Young in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Kayla Young works with at each company, as listed on that company's latest Form D.
Phase Genomics, Inc. · Form D, Mar 21, 2023
SS
Shawn Sullivan
Executive officer and promoter
IL
Ivan Liachko
Chief Executive Officer and director